Actively Recruiting
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Led by CNAO National Center of Oncological Hadrontherapy · Updated on 2025-08-06
180
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Quality of Life of patients treated with hadrontherapy is still limited. Two cohorts are established, they will be receiving specific standardized questionnaires to be evalutaed in their results.
CONDITIONS
Official Title
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with at least a follow-up of 5 years with head and neck, skull base, or brain tumors and no evidence of progressive disease (Cohort A)
- Patients able to give consent
- Histological and/or radiological diagnosis of head and neck tumors (Cohort B)
- Patients who are candidates for curative intent hadrontherapy (Cohort B)
- Patients aged 18 years or older (Cohort B)
You will not qualify if you...
- Previous re-irradiation
- Presence of a second tumor
- Known psychiatric or neurological diseases leading to disability that could impair questionnaire completion or affect quality of life (e.g., manic disorder, schizophrenia)
- Presence of diffuse metastasis (Cohort B)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CNAO
Pavia, Pv, Italy, 27100
Actively Recruiting
Research Team
A
Anna Maria Camarda
CONTACT
C
Cristina Bono
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here